Reducing agents used for end-cap removal of immunoglobulins or their antigen-binding fragments.

TW202631646APending Publication Date: 2026-08-01TORAY INDUSTRIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
TORAY INDUSTRIES INC
Filing Date
2025-09-26
Publication Date
2026-08-01
Patent Text Reader

Abstract

A compound formed by combining multiple water-soluble functional groups with triarylphosphine compounds represented by the following chemical formulas as a reducing agent for an active ingredient can be used as a reducing agent to selectively remove the end cap of cysteine ​​residues (amino acid number 80 according to Kabat) in the variable region of the light chain of immunoglobulins or their antigen-binding fragments (R1, R2 and R3 are each independently aryl or heteroaryl).
Need to check novelty before this filing date? Find Prior Art